Intelligent Medical Imaging (IMI) gets clearance for Micro21 applications:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared two new tests for Intelligent Medical Imaging's Micro21 system, reticulocyte counting and anti-nuclear antibody analysis. Micro21, a neural network microscopy system is marketed by Coulter.